drugset

drugset / Trial / NCT00396448

Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

NCT00396448 ↗

Phase 3 Terminated 1253 enrolled Pfizer

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to examine the long-term weight loss and safety of CP-945,598 in obese adults

Timeline

Start: 2007-02
Primary completion: 2009-02
Completion: 2009-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	OTENABANT	Small molecule	—	—

Indications